Company News in the Life Science Industry

»

Reset 

Crafoord Prize Awarded for Discovery of Miniscule Organism

BOX, Sweden, Jan. 18, 2019 /PRNewswire/ -- This year's Crafoord Prize has been awarded to Sallie Chisholm for the discovery of and research into Prochlorococcus, a very small cyanobacteria of huge importance. The prize amount is 6 million Swedish krona.

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2019

Wearable Medical Devices Market is Expected to Rise up to US$10 Billion by 2023, Says TMR

ALBANY, New York, January 18, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2019
Related companies:  Transparency Market Research

Immunomedics Receives Complete Response Letter From FDA for Sacituzumab Govitecan Biologics License Application

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  Immunomedics, Inc.

Sunesis Announces Pricing of $20 Million Offering of Securities

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  Sunesis Pharmaceuticals, Inc.

ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019

PharmaHopers Explains How to Earn Profit in Pharma Franchise Business

PANCHKULA, India, January 18, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2019

Diagnomics Introduces ACMG 59 Reports for Personalized Genetic Testing

SAN DIEGO, Jan. 17, 2019 /PRNewswire/ -- Diagnomics, a leading genetic testing company, has developed a new ACMG 59 report that is available to healthcare providers and their patients to complement Diagnomics' portfolio of Personalized Genomics. Diagnomics has partnered with Fabric Genomics to... Read more ››

By: PR Newswire Association LLC. - 18 Jan 2019
Related companies:  Diagnomics, Inc.

Aratana Therapeutics' Board of Directors Appoints Craig Tooman Chief Executive Officer

LEAWOOD, Kan., Jan. 17, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, announced today the Company's Board of Directors has appointed Craig Tooman... Read more ››

By: PR Newswire Association LLC. - 18 Jan 2019
Related companies:  Aratana Therapeutics, Inc.

FDA Advisory Committee Votes on Zynquista™ (sotagliflozin) as Treatment for Adults With Type 1 Diabetes

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  LEXICON PHARMACEUTICALS, INC.

Lexicon Pharmaceuticals to Host Conference Call and Webcast on January 17, 2019 to Discuss Outcome of FDA Advisory Committee Meeting for Sotagliflozin in Type 1 Diabetes

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  LEXICON PHARMACEUTICALS, INC.

Sanofi: FDA advisory committee votes on Zynquista(TM) (sotagliflozin) as treatment for adults with type 1 diabetes

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019

Muhammad Yasser Darkazally, M.D. is recognized by Continental Who's Who

TULSA, Okla., Jan. 17, 2019 /PRNewswire/ -- Muhammad Yasser Darkazally, M.D. is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Internal Medicine in recognition of his role as an Internist at Saint Francis Hospitalists.

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2019

Taiho Oncology and Servier Present Data on LONSURF® (trifluridine/tipiracil) at ASCO 2019 Gastrointestinal Cancers Symposium (ASCO GI)

PRINCETON, N.J., Jan. 17, 2019 /PRNewswire/ -- Taiho Oncology, Inc. and Servier announced today that the safety and efficacy in patients with gastrectomy from the global Phase 3 TAGS trial evaluating LONSURF(®) in patients with previously treated metastatic gastric cancer (mGC) are consistent... Read more ››

By: PR Newswire Association LLC. - 18 Jan 2019
Related companies:  Taiho Ventures, LLC

The healthcare business analytics market is projected to reach USD 50.5 billion by 2024 from USD 14.0 billion in 2019, at a CAGR of 28.3%

NEW YORK, Jan. 17, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2019

Brain Tumor Funders' Collaborative Announces $3 Million in Grants

CHICAGO, Jan. 17, 2019 /PRNewswire/ -- The Brain Tumor Funders' Collaborative (BTFC) - six funders of brain tumor research - just announced $3 million in grants to four multi-institutional teams of researchers and clinicians studying immunotherapy in primary brain tumors.

Read more ››
By: PR Newswire Association LLC. - 18 Jan 2019

HEXO Corp. announces results of annual general meeting

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019

Avivagen Announces CEO Letter to Shareholders

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Avivagen Inc.

ContraFect Announces Additional $2.3 Million in Funding from CARB-X to Support Gram-Negative Lysin Program

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Contrafect Corporation

Zafgen Announces Positive Results for Second Cohort of Phase 2 Clinical Trial of ZGN-1061

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Zafgen Inc.

AVROBIO, Inc. Announces Analyst and Investor Event and Upcoming Clinical Data Presentations at WORLDSymposium 2019

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Avrobio Inc.
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies